2025 Abstracts

Abstract #1: Incidence and Severity of Virus-associated Hemorrhagic Cystitis in Adult Allogeneic Hematopoietic Cell Transplant Recipients with Post -Transplant Cyclophosphamide - based GVHD Prophylaxis Maria Gianniki, MD, MS | Memorial Sloan Kettering Cancer Center

Abstract #2: Improving Tools Towards Individualized Risk Prediction and Management of BK Virus Infection in Renal Transplant Recipients Bin Ni, MD | Duke University

Abstract #3: BKV-associated Hemorrhagic Cystitis after Allogeneic HCT: Preliminary Data from a Retrospective Cohort Study Leonardo M. Parra | Hospital Dr Amaral Carvalho, Brazil

Best Abstract Oral: Probable CMV Pneumonia in Non-transplant Population with Hematologic Malignancies Karolina Bełdzińska-Gądek, MD | Medical University of Gdańsk, Poland

Abstract #4: Cytomegalovirus Modulation of CD8 T Cell Phenotype and Function in People Living with HIV-1 Brandi Clark, PhD | St Jude Children’s Research Hospital

Abstract #5: CMV Infection after Autologous Hematopoietic Stem Cell Transplantation for Non-Malignant Autoimmune Conditions Brennan Collis, MD | Duke University

Abstract #6: Outcomes of Clinically Significant Breakthrough CMV Infections while on Letermovir Prophylaxis Compared to Pre-emptive Strategy in Allogeneic Hematopoietic Cell Transplant Recipients Marilyne Daher | The University of Texas MD Anderson Cancer Center

Abstract #7: Preferences and Practices in CMV Management, Including CMV Cell-mediated Immunity Testing in a Large Academic Transplant Center Kyle T. Enriquez, MSc | Vanderbilt University Medical Center

Abstract #8: Antigen-agnostic Screening to Develop Broadly Protective Antibodies for Immunotherapy against Human Cytomegalovirus Hannah Lewis, PhD | Fred Hutch Cancer Center

Abstract #9: Cytomegalovirus Chorioretinitis Associated with Teclistimab in a Relapsed/Refractory Multiple Myeloma Patient Christopher Marino, MD | University of Pittsburgh Medical Center

Abstract #10: Evaluation of Risk of CMV Reactivation in Dasatinib-treated Patients Lubna Osman, MD | Jackson Memorial Hospital; University of Miami

Abstract #11: Risk Factors for Cytomegalovirus (CMV) Transmission from CMV Seropositive Donors to Seronegative Allogeneic Hematopoietic Cell Transplant (HCT) Recipients: Significance of Cell Product Composition and Post-transplant Immunosuppression Clarissa Santiano | Fred Hutch Cancer Center

Abstract #12: Home Infusion Short Course Remdesivir for Solid Organ Transplant Patients with COVID-19 Grace DeMarco, MD | MedStar Georgetown University Hospital

Best Abstract Oral (#71): Shifting Trends in Respiratory Viral Infection Outcomes Among Patients with Hematology Malignancies During 2023-2024 Respiratory Viral Season Tali Shafat Fainguelernt, PhD | The University of Texas MD Anderson Cancer Center

Abstract #13: Virological Analysis of Severely Immunocompromised Patients Infected with Human Parainfluenza Virus Trevor Gale, PhD | Asun BioPharma

Abstract #14: COVID-19 Vaccine Responses in Potentially Immunosuppressed Pregnant Individuals Connor Hague | University of Washington

Abstract #15: Measuring Vaccine Responses following Immunoablative Cancer Therapy using Sequencing Based Neutralization Assays for Influenza Catherine Jacob-Dolan, PhD | Fred Hutch Cancer Center

Abstract #16: Hematopoietic Cell Transplant Recipients Produce More Respiratory Syncytial Virus Antibodies against the Attachment Protein (G) than Fusion Protein (F) Antibodies Sara Ruth Kim, MD | Seattle Children’s Hospital

Abstract #17: Re-defining Vulnerability to COVID-19 in Cancer Patients: An Analysis of Mortality from the ISARIC WHO Clinical Characterisation Protocol Cancer UK Prospective Cohort Study Rebecca Lenihan, BMBCh | University of Liverpool, United Kingdom

Abstract #18: Strategizing Inpatient Delivery of Pemivibart: Lessons from a Single-Center Tixagevimab/Cilgavimab Quality Improvement Initiative Christopher Marino, MD | University of Pittsburgh Medical Center

Abstract #19: A Retrospective Descriptive Analysis of Respiratory Syncytial Virus Infection after Allogenic Hematopoietic Stem Cell Transplantation Anna Nordlander, MD, PhD | Karolinska University Hospital, Sweden

Abstract #20: Exanthematous Eruption in a Patient with Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination Bianca Patel | Morehouse School of Medicine

Abstract #21: T-cell responses to Influenza and RSV vaccination in Allogeneic Haematopoietic Stem Cell Transplant Recipients Ellen Walsh, MBBCh, MSc | St. James Hospital Dublin, Ireland 

Abstract #22: Diagnosis of Invasive Fungal Diseases by Microbial Cell-Free DNA in the Immunocompromised Patient: A Descriptive Review Update Melissa Kerkelis, MD | Mayo Clinic

Abstract #23: Disseminated M. haemophilum Infection Involving the CNS in a Patient with History of Renal Transplant Xaviera Ortiz Soto, MD | University of Texas Health Science Center San Antonio

Abstract #24: Detecting Primary Effusion Lymphoma Using HHV8 Cell-free DNA Methylation Markers Sabina Pathan, MD, MHS | National Institutes of Health

Abstract #25: Single-Center Organ Procurement Organization Assessment of Trypanosoma cruzi Screening in Potential Organ Donors Stella Radosta, MD, MS | University of Texas Southwestern Medical Center

Abstract #26: Evaluation of Respiratory Risk Scores for Predicting Outcomes in Lower Respiratory Tract Infections Among Non-Transplant Hematologic Patients Karolina Bełdzińska-Gądek, MD | Medical University of Gdańsk, Poland

Abstract #27: Clinical Outcomes in Lung Transplantation in People Living with HIV: A Competing Risk Analysis German A. Contreras, MD, MSc | University of Texas Medical School Galveston

Abstract #28: Endobronchial Mass as a Presentation of Mycobacterium Kansasii Infection in Myelofibrosis on Ruxolitinib - A Case Report Ren Dongdong, MBBS | Tan Tock Seng Hospital, Singapore

Abstract #29: Single Center Experience with Peri- and Post-operative Mycoplasma/Ureaplasma (Mollicute) Molecular Testing in Lung Transplant Recipients as Part of a Hyperammonemia Syndrome Prevention Protocol Luke Fenlon, MD | University of Utah

Best Abstract Oral: Early Host Blood Transcriptional Signatures Predictive of Lower Respiratory Tract (LRT) Disease Progression during Parainfluenza Infection in Hematopoietic Cell Transplant (HCT) Recipients Fang Yun Lim, PhD | Fred Hutch Cancer Center

Abstract #30: Pneumocystis Pneumonia after Chimeric Antigen Receptor T-cell (CAR-T) Therapy: A Systematic Review and Meta-analysis Bibi Maryam, MD | University of Oklahoma Health Sciences

Abstract #31: Incidence of Sexually Transmitted Diseases in Patients Undergoing Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy: A Large Database Analysis of the United States Data Chia-Yu Chiu, MD | University of Colorado

Abstract #32: Preventing Donor-derived HHV-8: Is Screening with Serology Enough? Julie England, MD, MPAS | University of Texas Southwestern Medical Center

Abstract #33: Altered Expression of IgG and FcRn in Intestinal Tissue of Hematopoietic Stem Cell Transplant Recipients Lea Kipnis | Fred Hutch Cancer Center

Abstract #34: Neutrophil Function against Candida albicans is Preserved following Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplant Maria Lampou | Massachusetts General Hospital

Abstract #35: Decoding Low HIV Viral Reservoirs: Insights from 3 US Cohorts of People Virologically Suppressed on ART Nancy Liu | Morehouse School of Medicine

Abstract #36: A Retrospective Study on Infection-Related Mortality after Outpatient CAR-T Cell Therapy Bibi Maryam, MD | University of Oklahoma Health Sciences

Best Abstract Oral (#72): Incidence of Breakthrough HSV in Adult Allogeneic Hematopoietic Cell Transplant Recipients on Standardized Antiviral Prophylaxis Ria Mohan | Virginia Commonwealth University

Abstract #37: Immune Response to Routine Vaccination in Patients after CAR-T Cell Therapy for B Cell Malignancies Stosh Ozog, MD PhD | Fred Hutch Cancer Center

Abstract #38: “To Draw or Not to Draw”: Does Obtaining Peripheral Blood Cultures Change Outcomes in Febrile Neutropenia in Children with Cancer? Muayad Alali, MD | Indiana University

Abstract #39: An International Survey Establishing Current Infection Prevention and Surveillance Practice in the Care of the Australasian Cancer and Transplant Population (INTERACT Study) Priya Garg, MBBS | Peter MacCallum Cancer Centre, Australia

Abstract #40: Minding the Gap: Impact of Sulfonamide Allergy Label in Kidney Transplant Recipients Jennifer Hu, MD | University of Washington

Abstract #41: Trending Intestinal Microbiome and Metabolome Fluctuations in Patients Receiving Intense Chemotherapy for Aml: Results from A Pilot, Prospective Observational Study Sabrina Imam, MD | University of Chicago

Abstract #42: CYP2C19 Pharmacogenomic Voriconazole Dosing: Impact on Clinical Management and Level Attainment Julian Lindsay, BPharm, MClinPharm, PhD | Fred Hutch Cancer Center

Abstract #43: Effectiveness of Non-Quinolone-Based Antibiotic Prophylaxis in Pediatric Acute Myeloid Leukemia with High-Dose Cytarabine-Containing Chemotherapy Toshihiro Matsui, MD, PhD | National Center for Child Health and Development, Japan

Abstract #43.5: Aeromonas Bacteremia in Liver Transplant Recipients: A Case Series Toshihiro Matsui, MD, PhD | National Center for Child Health and Development, Japan

Abstract #44: Clinical Outcomes of Enteropathogenic Escherichia coli (EPEC) Detections by Multiplex Molecular Panel with Masked Results in Immunocompromised Hosts Sabrina Newstead, MD | University of Utah

Abstract #45: ID-led, Allergy-supported Beta-lactam Allergy De-labeling in Solid Organ Transplant Patients Ellie Oken, ARNP, DNP | University of Washington

Abstract #46: Effectiveness and Safety of Strategies to Optimise Antimicrobial Use in Solid Organ Transplant Recipients. Systematic Review and Meta-analysis María Paniagua García, MD, PhD | Hospital Universitario Virgen del Rocío, Spain

Abstract #47: Risk factors for Infection Development in Hematological Patients with Colonization of MDR-Enterobacterales Francesco Peracchi, MD | University of Milano-Biocca, Italy

Abstract #48: Impact of Cancer on the Incidence, Outcomes, and Trends of Catheter-Associated Bloodstream Infections: A Nationwide Analysis from Inpatient Hospitalizations (2016–2021) Anil Matthew Philip, MD | Kuriakose Chavara Memorial Hospital

Abstract #49: Management of Brucellosis in a Cardiac Transplant Recipient: A Case Report and Review of Cases Julieta L. Rodriguez, MD, MPH | University of California, San Francisco

Abstract #50: Characterization of Late Positive Blood Cultures and Late-Onset Bloodstream Infections in Persistent Febrile Neutropenia Emily Rosen, MD | Fred Hutch Cancer Center

Abstract #51: Nontyphoidal Salmonella in Immunocompromised Hosts: A Case Report and Discussion Syeda Sahra, MBBS | Mayo Clinic

Abstract #52: Severe Human Granulocytic Ehrlichiosis in an Immunosuppressed Host Syeda Sahra, MBBS | Mayo Clinic

Abstract #53: A Rare Case Presentation of Recurrent Porta Cath Associated Bloodstream Infection with Gordonia polyisoprenivorans in an Immune-compromised Host Ayesha Samreen, MBBS | Mayo Clinic

Abstract #54: Invasive Listeriosis in Immunocompromised Hosts- Retrospective Descriptive Study at a Tertiary Care Center in the United States Ayesha Samreen, MBBS | Mayo Clinic

Abstract #55: Clinical Experience with Gram-negative Blood-stream Infections in Pediatric HCT Recipients (2010-2023) Hayley Scheerer, MD | St. Jude Children’s Research Hospital

Abstract #56: Bloodstream Infection and Risk for Plasma Cell Neoplasms: A Large Population-based Cohort Study Adam Stewart, MBBS, MPH | Massachusetts General Hospital

Abstract #57: Donor-derived Tuberculosis in Three Solid Organ Transplant Recipients Paulina Vega, MD | Fred Hutch Cancer Center

Abstract #58: Factors Associated with Antimicrobial Utilization in Solid Organ Transplant Recipients: A Next Step in Further Understanding Antimicrobial Stewardship in the Solid Organ Transplant Population Emily Wong, MD | University of Texas Southwestern Medical Center

Abstract #59: Breakthrough Fusarium solani Aortitis with Neurovascular Complications Following Posaconazole Prophylaxis Alaa Atamna, MD | Beilinson Hospital, Israel

Abstract #60: Characterization of Solid Organ Transplant Recipients with Positive T2Candida Panel Presenting with Suspected Invasive Candidiasis Megha Jagannathan, MD | Henry Ford Hospital

Abstract #61: Fungal Infections and Treatment Outcomes in STAT1 and STAT3 Gain-of-Function Mutations: A Case Series Valerie Jaroenpuntaruk, MD | Mayo Clinic

Abstract #62: Aspergillus Galactomannan Assay in Bloody Bronchoalveolar Lavage Fluid: Investigating Factors Associated with False-Positive Results Mabel Jiminez, MD, MPH | Fred Hutch Cancer Center

Abstract #63: Post-transplant Outcomes in Kidney Transplant Recipients with Invasive Fungal Infections Prior vs. After Emergence of SARS-CoV2 Lucy Li, MD | Johns Hopkins University

Abstract #64: Cryptococcal Laryngitis Associated with Inhaled Medical Cannabis Use in a Multiple Myeloma Patient Christopher Marino, MD | University of Pittsburgh Medical Center

Abstract #65: Microsporidiosis Following Solid Organ Transplantation: A Case Series Jack McHugh, MBBS | Mayo Clinic

Abstract #66: All that Glitters is Not Cancer: Unexpected Diagnosis of a Skin Lesion in a Patient with Metastatic Melanoma Gabriel Motoa Cardona, MD | Massachusetts General Hospital; Brigham and Women’s Hospital

Abstract #67: Optimizing Liposomal Amphotericin B in Patients on Extracorporeal Membrane Oxygenation Utilizing Therapeutic Drug Monitoring Shiv Patel, MD | Medical College of Wisconsin

Abstract #68: Infectious Dermatologic Disease in Displaced Populations: A Systematic Review of Trends and Proactive Measures Nadia Siddiqui | University of Washington

Abstract #69: A Case of a Rare Disseminated Dimorphic Fungal Infection in a Kidney Transplant Recipient Rebecca Unterborn, MD | University of Colorado

Abstract #70: Pneumocystis jirovecii Pneumonia Following Bispecific Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Systematic Review and Meta-analysis Karan Srisurapanont, MD | Chiang Mai University, Thailand